Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34

Christopher D. Link, Carolyn J. Johnson, Virginia Fonte, Marie Christine Paupard, David H. Hall, Scot Styren, Chester A. Mathis, William E. Klunk

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Transgenic Caenorhabditis elegans animals can be engineered to express high levels of the human beta amyloid peptide (Abeta). Histochemistry of fixed tissue from these animals reveals deposits reactive with the amyloid-specific dyes Congo Red and thioflavin S (Fay et al., J. Neurochem 71:1616, 1998). Here we show by immuno-electron microscopy that these animals contain intracellular immunoreactive deposits with classic amyloid fibrillar ultrastructure. These deposits can be visualized in living animals using the newly developed, intensively fluorescent, amyloid-specific dye X-34. This in vivo staining allows monitoring of amyloid deposition in individual animals over time. The specificity of this staining is demonstrated by examining transgenic animals expressing high levels of a non-fibrillar beta peptide variant, the beta single-chain dimer. These animals have deposits immunoreactive with anti-beta antibodies, but do not have X-34 deposits or deposits with a fibrillar ultrastructure. X-34 can also be used in vivo to visualize putative amyloid deposits resulting from accumulation of human transthyretin, another amyloidic protein. In vivo amyloid staining with X-34 may be a useful tool for monitoring anti-amyloidic treatments in real time or screening for genetic alterations that affect amyloid formation.

Original languageEnglish (US)
Pages (from-to)217-226
Number of pages10
JournalNeurobiology of Aging
Volume22
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Amyloid Plaques
Caenorhabditis elegans
Amyloid
Coloring Agents
Staining and Labeling
Congo Red
Genetically Modified Animals
Prealbumin
Immunoelectron Microscopy
Amyloid beta-Peptides
Genetic Testing
1,4-bis(3-carboxy-4-hydroxyphenylethenyl)-benzene
Anti-Idiotypic Antibodies
Peptides
Proteins

Keywords

  • 4G8
  • Abeta
  • Amyloid
  • BSB
  • C. elegans
  • Fibrillar ultrastructure
  • Immuno-EM
  • In vivo staining
  • Transgenic
  • Transthyretin
  • X-34

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. / Link, Christopher D.; Johnson, Carolyn J.; Fonte, Virginia; Paupard, Marie Christine; Hall, David H.; Styren, Scot; Mathis, Chester A.; Klunk, William E.

In: Neurobiology of Aging, Vol. 22, No. 2, 2001, p. 217-226.

Research output: Contribution to journalArticle

Link, Christopher D. ; Johnson, Carolyn J. ; Fonte, Virginia ; Paupard, Marie Christine ; Hall, David H. ; Styren, Scot ; Mathis, Chester A. ; Klunk, William E. / Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. In: Neurobiology of Aging. 2001 ; Vol. 22, No. 2. pp. 217-226.
@article{88737e97cfe04ea89a9430453e0df1fd,
title = "Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34",
abstract = "Transgenic Caenorhabditis elegans animals can be engineered to express high levels of the human beta amyloid peptide (Abeta). Histochemistry of fixed tissue from these animals reveals deposits reactive with the amyloid-specific dyes Congo Red and thioflavin S (Fay et al., J. Neurochem 71:1616, 1998). Here we show by immuno-electron microscopy that these animals contain intracellular immunoreactive deposits with classic amyloid fibrillar ultrastructure. These deposits can be visualized in living animals using the newly developed, intensively fluorescent, amyloid-specific dye X-34. This in vivo staining allows monitoring of amyloid deposition in individual animals over time. The specificity of this staining is demonstrated by examining transgenic animals expressing high levels of a non-fibrillar beta peptide variant, the beta single-chain dimer. These animals have deposits immunoreactive with anti-beta antibodies, but do not have X-34 deposits or deposits with a fibrillar ultrastructure. X-34 can also be used in vivo to visualize putative amyloid deposits resulting from accumulation of human transthyretin, another amyloidic protein. In vivo amyloid staining with X-34 may be a useful tool for monitoring anti-amyloidic treatments in real time or screening for genetic alterations that affect amyloid formation.",
keywords = "4G8, Abeta, Amyloid, BSB, C. elegans, Fibrillar ultrastructure, Immuno-EM, In vivo staining, Transgenic, Transthyretin, X-34",
author = "Link, {Christopher D.} and Johnson, {Carolyn J.} and Virginia Fonte and Paupard, {Marie Christine} and Hall, {David H.} and Scot Styren and Mathis, {Chester A.} and Klunk, {William E.}",
year = "2001",
doi = "10.1016/S0197-4580(00)00237-2",
language = "English (US)",
volume = "22",
pages = "217--226",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34

AU - Link, Christopher D.

AU - Johnson, Carolyn J.

AU - Fonte, Virginia

AU - Paupard, Marie Christine

AU - Hall, David H.

AU - Styren, Scot

AU - Mathis, Chester A.

AU - Klunk, William E.

PY - 2001

Y1 - 2001

N2 - Transgenic Caenorhabditis elegans animals can be engineered to express high levels of the human beta amyloid peptide (Abeta). Histochemistry of fixed tissue from these animals reveals deposits reactive with the amyloid-specific dyes Congo Red and thioflavin S (Fay et al., J. Neurochem 71:1616, 1998). Here we show by immuno-electron microscopy that these animals contain intracellular immunoreactive deposits with classic amyloid fibrillar ultrastructure. These deposits can be visualized in living animals using the newly developed, intensively fluorescent, amyloid-specific dye X-34. This in vivo staining allows monitoring of amyloid deposition in individual animals over time. The specificity of this staining is demonstrated by examining transgenic animals expressing high levels of a non-fibrillar beta peptide variant, the beta single-chain dimer. These animals have deposits immunoreactive with anti-beta antibodies, but do not have X-34 deposits or deposits with a fibrillar ultrastructure. X-34 can also be used in vivo to visualize putative amyloid deposits resulting from accumulation of human transthyretin, another amyloidic protein. In vivo amyloid staining with X-34 may be a useful tool for monitoring anti-amyloidic treatments in real time or screening for genetic alterations that affect amyloid formation.

AB - Transgenic Caenorhabditis elegans animals can be engineered to express high levels of the human beta amyloid peptide (Abeta). Histochemistry of fixed tissue from these animals reveals deposits reactive with the amyloid-specific dyes Congo Red and thioflavin S (Fay et al., J. Neurochem 71:1616, 1998). Here we show by immuno-electron microscopy that these animals contain intracellular immunoreactive deposits with classic amyloid fibrillar ultrastructure. These deposits can be visualized in living animals using the newly developed, intensively fluorescent, amyloid-specific dye X-34. This in vivo staining allows monitoring of amyloid deposition in individual animals over time. The specificity of this staining is demonstrated by examining transgenic animals expressing high levels of a non-fibrillar beta peptide variant, the beta single-chain dimer. These animals have deposits immunoreactive with anti-beta antibodies, but do not have X-34 deposits or deposits with a fibrillar ultrastructure. X-34 can also be used in vivo to visualize putative amyloid deposits resulting from accumulation of human transthyretin, another amyloidic protein. In vivo amyloid staining with X-34 may be a useful tool for monitoring anti-amyloidic treatments in real time or screening for genetic alterations that affect amyloid formation.

KW - 4G8

KW - Abeta

KW - Amyloid

KW - BSB

KW - C. elegans

KW - Fibrillar ultrastructure

KW - Immuno-EM

KW - In vivo staining

KW - Transgenic

KW - Transthyretin

KW - X-34

UR - http://www.scopus.com/inward/record.url?scp=0035109444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035109444&partnerID=8YFLogxK

U2 - 10.1016/S0197-4580(00)00237-2

DO - 10.1016/S0197-4580(00)00237-2

M3 - Article

C2 - 11182471

AN - SCOPUS:0035109444

VL - 22

SP - 217

EP - 226

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 2

ER -